Reporte zur Charge IN259

Symptomtext

Given Pediarix instead of TDAP-IPV-HEP-B; inappropriate age at vaccine administration; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 14-year-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number IN259, expiry date 5th October 2023) for prophylaxis. Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 7th February 2022, the patient received the 2nd dose of Pediarix and Pediarix Pre-Filled Syringe Device. On 7th February 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter stated that, the 14 years old patient received dose of Pediarix instead of the combo TDAP-IPV-HEP-B, which led to wrong vaccine administered and inappropriate age at vaccine administration. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up.